RS739846 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| CTSZ protein levels | A | OR: 0.14 | 5E-51 | PubMed |
| Cirrhosis | A | OR: 0.3 | 3E-47 | PubMed |
| Cirrhosis | A | OR: 0.26 | 2E-44 | PubMed |
| MET protein levels | A | β: 0.085 | 9E-20 | PubMed |
| Type 2 diabetes mellitus or coronary artery disease (pleiotropy) | — | — | 2E-19 | PubMed |
| Tyrosine levels | A | β: 0.03 | 3E-19 | PubMed |
| Alanine transaminase levels in high alcohol intake | — | β: 0.024 | 1E-18 | PubMed |
| hematocrit (maximum, inv-norm transformed) | G | β: 0.042 | 3E-18 | PubMed |
| Phosphatidylcholine (40:7) (a) levels | A | — | 8E-18 | PubMed |
| FUOM protein levels | A | β: 0.09 | 1E-17 | PubMed |
| Aspartate transaminase levels in high alcohol intake | — | β: 0.016 | 3E-16 | PubMed |
| FTCD protein levels | A | β: 0.087 | 9E-16 | PubMed |
| SLC39A14 protein levels | A | β: 0.083 | 2E-14 | PubMed |
| GSTA1 protein levels | A | β: 0.075 | 6E-14 | PubMed |
| Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | G | OR: 0.11 | 1E-13 | PubMed |
| Fasting phospholipid levels in medium VLDL | A | OR: 0.28 | 5E-13 | PubMed |
| Fasting free cholesterol in medium VLDL | A | OR: 0.28 | 1E-12 | PubMed |
| ACY1 protein levels | A | β: 0.071 | 2E-12 | PubMed |
| Fasting total lipids in medium VLDL | A | OR: 0.28 | 2E-12 | PubMed |
| Biological Sibling: High cholesterol | G | β: 0.089 | 2E-12 | PubMed |